For the first time in New Jersey, a cannabis cultivation permit has been issued to a greenhouse by the Department of Health (DOH). TerrAscend Corp. announced today that its Boonton facility received the approval of the DOH to launch production efforts in a new greenhouse, and it didn’t waste any time getting started. It has already planted the first crop that will be ready to harvest at some point during the fourth quarter of the year.
The new cultivation facility is a 37,000-square-foot greenhouse, and it will cultivate marijuana for the medical marijuana market. This project includes a second phase that is expected to be completed by this October. This addition is meant to expand the company’s production capacity in NJ to a total of 140,000 square feet, which includes a section for indoor cultivation and post-harvest manufacturing capabilities. TerrAscend has space and resources to further expand its NJ operations to more than 240,000 square feet.
“This is an important milestone as we continue to expand our operations to meet growing patient demand for high-quality, medical products in New Jersey,” said Jason Ackerman, CEO of TerrAscend. “We’re exceptionally proud of the team’s efforts and look forward to accelerating our growth as the facility ramps up to full capacity.”
The idea with this production facility is to launch medical marijuana products in the Garden State this November.
Among the products the company will offer, there is raw flower, pre-rolls, extracted distillate and vaporizable oil.
TerrAscend’s Illera Healthcare will also bring to the state branded tinctures, topicals and blends with medical blends.
The permit was issued in January this year, and it constitutes one of the six permits that the state had approved for vertically integrated corporations. Since then, the company has been using a temporary on-site area while construction of its greenhouse was completed, and the production can be transferred there.